# FDA recall D-0998-2017

> **Valeant Pharmaceuticals North America LLC** · Class III · drug recall initiated 2017-06-28.

## Product

Obagi-C Rx System C-Therapy Night Cream, Net wt. 2 oz. (57g) bottle, Rx only, Distributed by OMP, Inc., Long Beach, CA Made in USA, NDC 62032-222-02

## Reason for recall

Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer carton which contain the complete instruction for use and safety information.

## Distribution

U.S. Nationwide

## Key facts

- **Recall number:** D-0998-2017
- **Recalling firm:** Valeant Pharmaceuticals North America LLC
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-06-28
- **Report date:** 2017-07-26
- **Termination date:** 2018-01-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Bridgewater, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0998-2017

## Citation

> AI Analytics. FDA recall D-0998-2017. Retrieved 2026-06-23 from https://api.ai-analytics.org/recall/D-0998-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*